药 团体标准 NSHENG PHAFRMACEUTICAL T/HENANPA011-2023 医疗机构钙通道阻滞剂类药品 评价指标体系 Evaluation indicators system of calcium channel blockers in medical institutions 2023-08-11发布 2023-08-18实施 河南省药学会 发布 目次 目次 前言 .. 引言 医疗机构钙通道阻滞剂类药品评价指标体系5 1.范围 .5 2.规范性引用文件 5 3.术语和定义 3.1药品Drug. .5 3.2医疗机构Medical Institution 5 3.3指标Indicator 6 3.4指标体系Indicator System. ...6 3.5钙通道阻滞剂Calcium Channel Blocker..6 3.6钙通道阻滞剂类药品评价指标Indicator of Calcium Channel Blocker.6 3.7钙通道阻滞剂类药品评价指标体系Indicator System of Calcium Channel Blocker....................... 6 3.8一级评价指标First Grade Assessment Indicator. 6 3.9二级评价指标Second Grade Assessment Indicator.6 3.10三级评价指标Third Grade Assessment Indicator.6 3.11指标权重Indicator Weight- .6 3.12安全性评价Safety Evaluation. 6 3.13有效性评价Validity Evaluation.. .6 3.14经济性评价Economic Evaluation .7 3.15创新性评价Innovation Evaluation .7 3.16适宜性评价Suitability Evaluation. 7 3.17可及性评价Accessibility Evaluation. .7 4.评价指标体系 .7 4.1安全性评价 .7 4.2有效性评价 .8 4.3经济性评价 8 4.4适宜性评价 8 ...
T/HENANPA 011-2023 医疗机构钙通道阻滞剂类药品评价指标体系.pdf
![药品,评价指标体系,其他规范](https://www.guifanku.com/wp-content/uploads/2024/04/thumb812616.jpg)